Cost-effectiveness of highly active antiretroviral therapy in South Africa

 

Show simple item record

dc.contributor.author Badri, Motasim en_ZA
dc.contributor.author Maartens, Gary en_ZA
dc.contributor.author Mandalia, Sundhiya en_ZA
dc.contributor.author Bekker, Linda-Gail en_ZA
dc.contributor.author Penrod, John R en_ZA
dc.contributor.author Platt, Robert W en_ZA
dc.contributor.author Wood, Robin en_ZA
dc.contributor.author Beck, Eduard J en_ZA
dc.date.accessioned 2015-11-23T12:25:45Z
dc.date.available 2015-11-23T12:25:45Z
dc.date.issued 2005 en_ZA
dc.identifier.citation Badri, M., Maartens, G., Mandalia, S., Bekker, L., Penrod, J. R., Platt, R. W., ... & Beck, E. J. (2006). Cost-effectiveness of highly active antiretroviral therapy in South Africa. PLoS Medicine, 3(1), 48. doi:10.1371/journal.pmed.0030004 en_ZA
dc.identifier.uri http://hdl.handle.net/11427/15283
dc.identifier.uri http://dx.doi.org/10.1371/journal.pmed.0030004
dc.description.abstract Healthcare costs for HIV-infected South African adults on HAART compared with costs for HIV-infected controls not on HAART. Authors conclude HAART is cost effective. en_ZA
dc.language.iso eng en_ZA
dc.publisher Public Library of Science en_ZA
dc.rights This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. en_ZA
dc.rights.uri http://creativecommons.org/licenses/by/4.0 en_ZA
dc.source PLOS Medicince en_ZA
dc.source.uri http://journals.plos.org/plosmedicine en_ZA
dc.subject.other Highly-active antiretroviral therapy en_ZA
dc.subject.other AIDS en_ZA
dc.subject.other Inpatients en_ZA
dc.subject.other Outpatients en_ZA
dc.subject.other HIV en_ZA
dc.subject.other Antiretroviral therapy en_ZA
dc.subject.other Cost-effectiveness analysis en_ZA
dc.subject.other HIV infections en_ZA
dc.title Cost-effectiveness of highly active antiretroviral therapy in South Africa en_ZA
dc.type Journal Article en_ZA
dc.rights.holder © 2006 Badri et al en_ZA
uct.type.publication Research en_ZA
uct.type.resource Article en_ZA
dc.publisher.institution University of Cape Town
dc.publisher.faculty Faculty of Health Sciences en_ZA
dc.publisher.department Desmond Tutu HIV Centre en_ZA
uct.type.filetype Text
uct.type.filetype Image
dc.identifier.apacitation Badri, M., Maartens, G., Mandalia, S., Bekker, L., Penrod, J. R., Platt, R. W., ... Beck, E. J. (2005). Cost-effectiveness of highly active antiretroviral therapy in South Africa. <i>PLOS Medicince</i>, http://hdl.handle.net/11427/15283 en_ZA
dc.identifier.chicagocitation Badri, Motasim, Gary Maartens, Sundhiya Mandalia, Linda-Gail Bekker, John R Penrod, Robert W Platt, Robin Wood, and Eduard J Beck "Cost-effectiveness of highly active antiretroviral therapy in South Africa." <i>PLOS Medicince</i> (2005) http://hdl.handle.net/11427/15283 en_ZA
dc.identifier.vancouvercitation Badri M, Maartens G, Mandalia S, Bekker L, Penrod JR, Platt RW, et al. Cost-effectiveness of highly active antiretroviral therapy in South Africa. PLOS Medicince. 2005; http://hdl.handle.net/11427/15283. en_ZA
dc.identifier.ris TY - Journal Article AU - Badri, Motasim AU - Maartens, Gary AU - Mandalia, Sundhiya AU - Bekker, Linda-Gail AU - Penrod, John R AU - Platt, Robert W AU - Wood, Robin AU - Beck, Eduard J AB - Healthcare costs for HIV-infected South African adults on HAART compared with costs for HIV-infected controls not on HAART. Authors conclude HAART is cost effective. DA - 2005 DB - OpenUCT DO - 10.1371/journal.pmed.0030004 DP - University of Cape Town J1 - PLOS Medicince LK - https://open.uct.ac.za PB - University of Cape Town PY - 2005 T1 - Cost-effectiveness of highly active antiretroviral therapy in South Africa TI - Cost-effectiveness of highly active antiretroviral therapy in South Africa UR - http://hdl.handle.net/11427/15283 ER - en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Except where otherwise noted, this item's license is described as This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.